The PD-L1 antigen on tumor cells interacts with PD-1 on the surface of the cytotoxic CD8+ T cells to inhibit their activity and stimulate Treg cell development, thereby suppressing the immune response [113]. The gene discussed is CD8A; the disease is neoplasm.